Add BrightSurf on Google Email

Max Planck Institute of Immunobiology and Epigenetics


Revisiting gene dosage

A study by Max Planck researchers has discovered an epigenetic regulator MSL2 that ensures the expression of both alleles of haploinsufficient genes, crucial for human health. This mechanism allows for tissue- and cell-type specificity in gene dosage, opening new directions for understanding diseases and developing potential treatments.

SourceMax Planck Institute of Immunobiology and Epigenetics·JournalNature·TypeExperimental study·DateNov 29, 2023

Sulfur: the consequences

A team of scientists found that sulfur metabolism plays a crucial role in the transition from single-celled to multicellular organisms. By manipulating sulfur levels, they were able to induce or prevent the formation of multicellular aggregates in the slime mold Dictyostelium discoideum. This discovery has significant implications for ...